Up next

Autoplay

Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms

2 Views • 07/29/23
Share
Embed
administrator
administrator
Subscribers
0

Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay